VALYSTR · Stock research
Listed on NYSE. What the market is pricing into AbbVie (ABBV) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $505B · P/E 49.2 · revenue $66.0B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows